Three buyback offers worth a combined ₹1,185 crore are shutting on Wednesday; here’s everything eligible shareholders need to know before the window closes.
Key Takeaways
- Buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems & Software are closing today, June 10, 2026.
- The three offers together are valued at approximately ₹1,185 crore, with Zydus alone accounting for ₹1,100 crore.
- All three are tender-route buybacks; only shareholders who held shares on the respective May 2026 record dates are eligible; fresh positions do not qualify.
- Dhanuka Agritech offers the steepest buyback premium at ~29% over its last closing price.
- Small shareholders get preferential entitlement ratios in all three offers, making this more accessible to retail investors.
Buyback Comparison — Closing June 10, 2026
| Company | Buyback Price | Premium vs CMP | Total Size | Small Shareholder Entitlement |
|---|---|---|---|---|
| Zydus Lifesciences Pharma |
₹1,260 | ~14% premium | ₹1,100 Cr | 5 shares per 49 held |
| Dhanuka Agritech Agrochem |
₹1,400 | ~29% premium | ₹70 Cr | 1 share per 15 held |
| CyberTech Systems IT |
₹170 | ~23% premium | ₹14.45 Cr | 12 shares per 277 held |
What Is a Share Buyback and Why Does It Matter to You?
A share buyback (or repurchase) is a corporate action where a company buys back its own equity from existing shareholders, typically at a price above the prevailing market rate. For eligible investors, this creates an opportunity to exit part of their holding at a guaranteed premium without impacting open-market prices.
Under the tender-route mechanism used by all three companies here, shareholders submit (or “tender”) a specified number of shares during the offer window. Acceptance is subject to entitlement ratios set by the company, and the small shareholder category (generally investors holding shares worth up to ₹2 lakh on the record date) gets a reserved, more favourable quota.
Important: The record dates for all three buybacks have already lapsed in May 2026. Investors who bought shares after the record date are not eligible to participate, regardless of their current holding.
Zydus Lifesciences Buyback — ₹1,100 Crore at ₹1,260 per Share
Offer details
Zydus Lifesciences is repurchasing 87.3 lakh equity shares at a buyback price of ₹1,260 per share, representing a premium of approximately 14% over the NSE closing price of ₹1,105.6 on the previous trading session.
This is the largest-ever buyback announced by Zydus Lifesciences, underscoring management’s confidence in the company’s cash generation and balance sheet strength.
Entitlement ratio
- Small shareholder category: 5 equity shares for every 49 shares held on the record date.
- General category: 7 equity shares for every 937 shares held on the record date.
Shareholding context
Before the buyback announcement, promoters and promoter group entities held nearly 75% of Zydus Lifesciences as of May 15, 2026. Retail investors and mutual funds each held around 5%, foreign portfolio investors (FPIs) held approximately 7%, and insurance companies held just over 6%.
Check Live on Niftytrader: ZYDUS LIFESCIENCES Max Pain Live Chart For NSE
Dhanuka Agritech Buyback — ₹70 Crore at ₹1,400 per Share
Offer details
Dhanuka Agritech is buying back up to 5 lakh shares at ₹1,400 per share — a premium of nearly 29% over the NSE closing price of ₹1,087.10. At ₹70 crore, this is the smallest of the three offers in absolute size, but the premium on offer is the most attractive of the lot.
Entitlement ratio
- Small shareholder category: 1 equity share for every 15 shares held on the record date.
- General category: 5 equity shares for every 518 shares held on the record date.
The thin general-category entitlement (5 in 518) means the acceptance ratio for large holders is expected to be low. Small shareholders, by contrast, can tender 1 in every 15 shares, a comparatively generous ratio for a ₹70 crore offer.
Check live on Niftytrader: DHANUKA AGRITECH Share Price Chart
CyberTech Systems & Software Buyback — ₹14.45 Crore at ₹170 per Share
Offer details
CyberTech Systems & Software is repurchasing 8.5 lakh shares, representing 9.81% of its total equity, at a buyback price of ₹170 per share. The aggregate buyback size is capped at ₹14.45 crore. The offer price implies a premium of more than 23% over the previous NSE closing price of ₹137.71.
Entitlement ratio
- Both small shareholder and general category: 12 equity shares for every 277 shares held on the record date.
Unlike Zydus and Dhanuka, CyberTech has set the same entitlement ratio for both categories.
Should You Tender Your Shares?
A buyback is not a guaranteed full-exit opportunity. The entitlement ratio determines only how many shares you can tender; the actual acceptance depends on overall participation within each category. Here are the key considerations:
Check your category first. If you held shares worth ₹2 lakh or less (at issue price) on the record date, you likely qualify under the small shareholder quota, which typically has a higher acceptance probability.
Compare the premium against the current market price. If the stock is already trading near or above the buyback price in the open market, tendering may not be the better option.
Tax treatment matters. Buyback proceeds are subject to applicable tax rules. Consult a tax adviser to understand your post-tax realisation.
Untendered shares continue as normal. If your shares are not accepted, they are returned to your demat account automatically. Buyback participation carries no penalty for non-acceptance.
[ Data CTA: Track FII-DII flows and open interest data for Zydus Lifesciences and other stocks in real time on the [NiftyTrader FII-DII Dashboard →]]
Bottom Line
Three corporate buybacks worth ₹1,185 crore in aggregate are closing today, offering eligible shareholders a final window to tender shares at premiums ranging from 14% (Zydus) to 29% (Dhanuka).
Zydus Lifesciences dominates in deal size with its record ₹1,100 crore offer, while Dhanuka Agritech leads on the premium percentage.
All three offers are via the tender route, and only shareholders on the respective May 2026 record dates can participate.
If you are eligible, today is the last opportunity; check your demat account entitlement and decide before the window shuts.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Please consult a SEBI-registered financial adviser before making any investment decisions.
